Open AccessDevelopment and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial
Author(s) -
Nathalie Asherie,
Shlomit KfirErenfeld,
Batia Avni,
Miri Assayag,
Tatyana Dubnikov,
Nomi Zalcman,
Eyal Lebel,
Eran Zimran,
Adir Shaulov,
Marjorie Pick,
Yaël Cohen,
Irit Avivi,
Cyrille J. Cohen,
Moshe E. Gatt,
Sigal Grisariu,
Polina Stepensky
Publication year - 2022
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2022.281628
Subject(s) - medicine , cohort , chimeric antigen receptor , cytokine release syndrome , multiple myeloma , refractory (planetary science) , oncology , gastroenterology , immunotherapy , cancer , physics , astrobiology